Gene · 3663
Papers4,211
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 4,211
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC. | Front Oncol | 2022 | 35586489 | PubTator, text mining | PubMed |
| COMMD2 Upregulation Mediated by an ncRNA Axis Correlates With an Unfavorable Prognosis and Tumor Immune Infiltration in Liver Hepatocellular Carcinoma. | Front Oncol | 2022 | 35574298 | PubTator, text mining | PubMed |
| Interaction Between Non-Coding RNAs and Interferons: With an Especial Focus on Type I Interferons. | Front Immunol | 2022 | 35572537 | PubTator, text mining | PubMed |
| Interferon regulatory factor-5-dependent CD11c+ macrophages contribute to the formation of rupture-prone atherosclerotic plaques. | Eur Heart J | 2022 | 35567557 | PubTator, text mining | PubMed |
| New therapeutic targets to reduce inflammation-associated cardiovascular risk: the CCL2-CCR2 axis, LOX-1, and IRF5. | Eur Heart J | 2022 | 35567553 | PubTator, text mining | PubMed |
| Systemic Scleroderma-Definition, Clinical Picture and Laboratory Diagnostics. | J Clin Med | 2022 | 35566425 | PubTator, text mining | PubMed |
| MicroRNAs as Regulators of Phagocytosis. | Cells | 2022 | 35563685 | PubTator, text mining | PubMed |
| Revealing the Immune Heterogeneity between Systemic Lupus Erythematosus and Rheumatoid Arthritis Based on Multi-Omics Data Analysis. | Int J Mol Sci | 2022 | 35563556 | PubTator, text mining | PubMed |
| Macrophage Dysfunction in Autoimmune Rheumatic Diseases and Atherosclerosis. | Int J Mol Sci | 2022 | 35562903 | PubTator, text mining | PubMed |
| TMPRSS2 Serves as a Prognostic Biomarker and Correlated With Immune Infiltrates in Breast Invasive Cancer and Lung Adenocarcinoma. | Front Mol Biosci | 2022 | 35558557 | PubTator, text mining | PubMed |
| Integrative Multi-Omics Analysis of Identified SKA3 as a Candidate Oncogene Correlates with Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma. | Int J Gen Med | 2022 | 35535142 | PubTator, text mining | PubMed |
| Novel brown adipose tissue candidate genes predicted by the human gene connectome. | Sci Rep | 2022 | 35534514 | PubTator, text mining | PubMed |
| Management of Connective Tissue Disease-related Interstitial Lung Disease. | Curr Pulmonol Rep | 2022 | 35530438 | PubTator, text mining | PubMed |
| EpCAM as a Novel Biomarker for Survivals in Prostate Cancer Patients. | Front Cell Dev Biol | 2022 | 35517503 | PubTator, text mining | PubMed |
| Prioritization of autoimmune disease-associated genetic variants that perturb regulatory element activity in T cells. | Nat Genet | 2022 | 35513721 | PubTator, text mining | PubMed |
| Comprehensive analysis to identify noncoding RNAs mediated upregulation of maternal embryonic leucine zipper kinase (MELK) correlated with poor prognosis in hepatocellular carcinoma. | Aging (Albany NY) | 2022 | 35511171 | PubTator, text mining | PubMed |
| The X in seX-biased immunity and autoimmune rheumatic disease. | J Exp Med | 2022 | 35510951 | PubTator, text mining | PubMed |
| miRNAs-mediated overexpression of Periostin is correlated with poor prognosis and immune infiltration in lung squamous cell carcinoma. | Aging (Albany NY) | 2022 | 35508298 | PubTator, text mining | PubMed |
| Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling. | Arthritis Rheumatol | 2022 | 35507331 | PubTator, text mining | PubMed |
| The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy. | J Biomed Sci | 2022 | 35505345 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3663/papers?page=54